Immunocore Holdings (IMCR) Operating Leases (2019 - 2026)
Immunocore Holdings (IMCR) reported Operating Leases of $38.85 million for Q2 2026, down 8.7% from $42.56 million a year earlier and down 2.9% from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Immunocore Holdings posted Operating Leases of $41.56 million, up 3.5% from FY2024.
- Operating Leases has increased for three consecutive years, with a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
- By year, Operating Leases came in at $40.16 million in FY2024 (+12.8%), $35.61 million in FY2023 (+12.1%), $31.76 million in FY2022 (-9.0%) and $34.89 million in FY2021 (+4.9%).
- The Q2 2026 figure ranks as the lowest quarterly Operating Leases since Q2 2024.
- Year over year, Operating Leases gained in five of the last seven quarters, with growth averaging 7.6%.
- The high point for year-over-year Operating Leases in five years was Q2 2025 (growth of 27.3%); the low point was Q2 2026 (a decline of 8.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $40.03 million (Q1 2026), $41.56 million (Q4 2025) and $41.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Immunocore Holdings | 1.63 Bn | -1.86 Bn | 114.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.85 Mn |
| Mar 31, 2026 | 40.03 Mn |
| Dec 31, 2025 | 41.56 Mn |
| Sep 30, 2025 | 41.40 Mn |
| Jun 30, 2025 | 42.56 Mn |
| Mar 31, 2025 | 40.75 Mn |
| Dec 31, 2024 | 40.16 Mn |
| Sep 30, 2024 | 41.27 Mn |
| Jun 30, 2024 | 33.45 Mn |
| Mar 31, 2024 | 33.99 Mn |
| Dec 31, 2023 | 35.61 Mn |
| Jun 30, 2023 | 34.78 Mn |
| Dec 31, 2022 | 34.06 Mn |
| Sep 30, 2022 | 30.12 Mn |
| Dec 31, 2021 | 34.23 Mn |
| Dec 31, 2020 | 34.34 Mn |
| Dec 31, 2019 | 50.22 Mn |
API Access
Immunocore Holdings Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();